Fauci Warns Pre-Pandemic Normalcy Not Likely Until 'Well Into' or 'Towards the End of 2021'

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, was interviewed Friday by MSNBC's Andrea Mitchell. (Photo: MSNBC)

Fauci Warns Pre-Pandemic Normalcy Not Likely Until 'Well Into' or 'Towards the End of 2021'

The public health expert also addressed the need to reduce cases headed into fall, halted vaccine trials, and reported attempts to "muzzle" him.

As the number of confirmed Covid-19 cases in the United States surpassed 6.43 million and the nation's death toll topped 192,600, the federal government's top infectious disease expert warned Friday that life likely won't return to normal until sometime--perhaps late--in 2021.

During a televised interview, MSNBC's Andrea Mitchell asked Dr. Anthony Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases, about his comments earlier this week that it may not be safe to attend movie theaters or indoor events until a year after the U.S. has a safe, effective vaccine.

Fauci said that he remains confident the U.S. could have a vaccine for Covid-19 by the end of this year or early next year, "but by the time you mobilize the distribution of the vaccinations and you get the majority or more of the population vaccinated and protected, that's likely not gonna happen till the mid or end of 2021."

"If you're talking about getting back to a degree of normality which resembles where we were prior to Covid, it's gonna be well into 2021, maybe even towards the end of 2021," Fauci added, referencing the local and state level lockdowns and social distancing practices that have been implemented throughout this year.

A White House adviser, Fauci also disagreed with President Donald Trump's claim during a Thursday press briefing that the United States has "rounded the final turn" in the pandemic. Looking at the statistics, "they're disturbing," Fauci told Mitchell. "We're plateauing at around 40,000 cases a day and the deaths are around 1,000."

The expert expressed hope that the U.S. won't see a post-Labor Day Weekend surge in cases like what occurred after July 4 and Memorial Day, and stressed the importance of driving down infection numbers heading into the fall and winter months.

"What we don't want to see is going into the fall season, when people will be spending more time indoors--and that's not good for a respiratory borne virus--you don't want to start off already with a baseline that's so high," he said.

Fauci also denied that he has been influenced by the reported efforts of a Trump-allied official within the Department of Health and Human Services to muzzle him or otherwise guide what the expert says publicly about the pandemic.

Regarding AstraZeneca's decision earlier this week to halt human trials for a potential vaccine after a participant in the U.K. showed signs of a suspected adverse reaction, Fauci said the development was unfortunate but should also reassure the public that safety concerns are being taken seriously.

The trial delay came as AstraZeneca joined eight other pharmaceutical companies in pledging to "stand with science" amid alarm that Trump may pressure the industry and the Food and Drug Administration to approve a vaccine ahead of the general election. As Common Dreams reported Tuesday, public health experts responded to Big Pharma's promise with cautious optimism.

Join Us: News for people demanding a better world


Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place.

We're hundreds of thousands strong, but every single supporter makes the difference.

Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. Join with us today!

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.